Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics

Abstract

The pharmacotherapy of Type 2 Diabetes Mellitus (T2DM) has, in the past 60 years, been developing in unison with the advances in our understanding of diabetes athophysiology. As our knowledge developed and changed, so did appear new drugs which better and inmore targeted fashion rectified the pathological processes leading to the development of diabetes.

Keywords

• Diabetes mellitus type 2
• pharmacotherapy
• past 60 years
• treatment methods